大会主席Professor Dr Karen Sermon谈ESHRE组织使命与青年医生培养
2024年7月7-10日，第40届欧洲人类生殖与胚胎学学会（ESHRE）年会在荷兰阿姆斯特丹顺利召开。作为生殖医学领域规模最大、最具影响力的年度国际学术会议之一，ESHRE 2024聚集了来自生殖医学、胚胎学、生殖内分泌学、遗传学等多个领域内的专家学者，共同探讨领域内最新研究成果、目前的争议以及未来的发展方向，备受生殖医学领域专家学者的关注。
医说生殖（Trends in ART）平台作为ESHRE 2024特邀官方合作媒体，紧跟会议热点，并在阿姆斯特丹大会现场邀请生殖领域大咖，针对大会前沿热点话题进行了采访和现场报道。会议期间，我们有幸邀请到了大会主席、来自比利时Vrije Universiteit Brussel的Professor Dr Karen Sermon，与大家分享了ESHRE成立40年以来的辉煌与成就，并表达了对青年生殖医生的殷切期望。
1. Would you please introduce the ESHRE for our Chinese Doctor?
ESHRE成立40年至今，是个历史底蕴丰厚的组织。我们最初成立的目的是为了生殖医学的教育和学科发展。随着我们发展壮大，到今天ESHRE成员有1万多名。本次大会有超过1万2千多名来自世界各地的注册参会专家学者。ESHRE作为欧洲生殖医学的领军组织，学会为欧洲生殖医学的发展做了很多努力。ESHRE一直致力于指南和共识的制定，为生殖科的医生们提供重要的实践建议和循证的医学观点。同时ESHRE拥有最早的胚胎医师认证体系，胚胎医师们通过考试获得初级或高级胚胎医师的认证。该认证在欧盟国家是具有权威性的。
这些年来，ESHRE为欧盟国家制定生育相关的法律和政策提供重要参考。ESHRE一直以科学性为核心，服务广大生殖医学同行，不忘初心，砥砺前行。
2.Could you plesae leave some words for our young Young Reproductive Physicians？
年轻的生殖科医生是我们的未来。在ESHRE的年会知识海洋中，有很多可以学习的地方，例如今年大会设立了生殖内分泌、生殖外科手术等多个分会主题，从多方面，多角度的对生殖医学新进展进行分类跟进汇报。年轻医生们来到我们年会现场可以与其他国家的同行交流，互相学习，这是难得的学习和交流的机会。同时ESHRE也希望能通过对学科新进展的汇报和展示，给医生们提供和巩固循证医学的思路。
专家风采
Professor Dr Karen Sermon
Vrije Universiteit Brussel
undefined
Vrije Universiteit Brussel
Belgium
Karen Sermon is professor in Genetics and Embryology at the Vrije Universiteit Brussel. She trained as an MD and received her PhD in medical sciences on preimplantation genetic diagnosis of Tay-Sachs disease at the same university. After her PhD, she became a postdoctoral fellow for the Fund for Scientific Research Flanders (Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen). During this period, her main interest was on PGD for monogenic diseases, which she helped develop at the Centre for Medical Genetics of the UZ Brussel. She was instrumental in founding the ESHRE PGD Consortium and has contributed to its success for many years as a chair. Later, she became coordinator of ESHRE’s Special Interest Group Reproductive Genetics. Since 2002, her interests have veered towards human embryonic stem cells, and especially those stem cells derived from PGD embryos that carry a monogenic disease and can be used as disease models. Her group have contributed to the stem cell field with several papers in high impact factor journals. She was coordinator of ESHRE’s special interest group Stem Cells. Recently, she also developed a research line in the origin of chromosomal abnormalities in preimplantation embryos. She was appointed coordinator of the ESTEEM study (ESHRE study into the evaluation of oocyte euploidy by microarray analysis - https://www.eshre.eu/Data-collection-and-research/ESTEEM).
